• SPX
  • $5,969.34
  • 0.35 %
  • $20.63
  • DJI
  • $44,296.51
  • 0.97 %
  • $426.16
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $19,003.65
  • 0.16 %
  • $31.23
GSK plc (GSK) Stock Price, News & Analysis

GSK plc (GSK) Stock Price, News & Analysis

Currency in USD Disclaimer

$33.96

$0.26

(0.77%)

Day's range
$33.77
Day's range
$34.15
50-day range
$32.83
Day's range
$43.62
  • Country: GB
  • ISIN: US37733W2044
52 wk range
$32.83
Day's range
$45.93
  • CEO: Ms. Emma Natasha Walmsley
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 1.85
  • Piotroski Score 6.00
  • Grade Neutral
  • Symbol (GSK)
  • Company GSK plc
  • Price $33.96
  • Changes Percentage (0.77%)
  • Change $0.26
  • Day Low $33.77
  • Day High $34.15
  • Year High $45.93

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

  • Last Earnings 10/30/2024
  • Ex-Dividend for 5/16 Dividend 11/15/2024
  • Dividend Payable 01/09/2025
  • Today N/A
  • Next Earnings (Estimated) 01/29/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $53.00
  • High Stock Price Target $85.00
  • Low Stock Price Target $36.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $2.78
  • Trailing P/E Ratio 14.82
  • Forward P/E Ratio 14.82
  • P/E Growth 14.82
  • Net Income $4.93 B

Income Statement

Quarterly

Annual

Latest News of GSK

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

GSK plc Frequently Asked Questions

  • What were the earnings of GSK in the last quarter?

    In the last quarter GSK plc earnings were on Wednesday, October, 30th. The GSK plc maker reported $1.27 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.11.

  • What is the GSK plc stock price today?

    Today's price of GSK plc is $33.96 — it has increased by +0.77% in the past 24 hours. Watch GSK plc stock price performance more closely on the chart.

  • Does GSK plc release reports?

    Yes, you can track GSK plc's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the GSK plc stock forecast?

    Watch the GSK plc chart and read a more detailed GSK plc stock forecast to see what analysts suggest you do with its shares.

  • What is GSK plc stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by GSK plc stock ticker.

  • How to buy GSK plc stocks?

    Like other stocks, GSK shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is GSK plc's EBITDA?

    GSK plc measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in GSK plc’s financial statements.

  • What is the GSK plc's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.1624901082, which equates to approximately 16.25%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in GSK plc stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including GSK plc's financials relevant news, and technical analysis. GSK plc's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for GSK plc stock currently indicates a “sell” signal. For more insights, review GSK plc’s technical analysis.

  • A revenue figure for GSK plc for its last quarter?

    GSK plc published it's last quarterly revenues at $8.01 B.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.